Abstracts - faqs.org

Abstracts

Retail industry

Search abstracts:
Abstracts » Retail industry

US: EXTRA CURRICULA ACTIVITIES BENEFIT CHILDREN

Article Abstract:

Research conducted over 16 years by the University of Arizona in the US suggests that children partaking in extra-curricula activities, such as drama groups and sports perform better in life than those solely concentrating on academic studies. The study was conducted on 2,200 subjects aged 11 to 27 years who were interviewed at the ages of 12, 13, 15, 16, 18, 21 and 24. The research was able to determine long-term life patterns from the type of extra-curricular activity undertaken, such as academic achievement and drug abuse. Extra-curricula activities were seen as giving teenagers the ability to formulate goals and be a success.

Publisher: Financial Times Ltd.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
Research Findings, Marketing, Research, Children, University of Arizona

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


US: ASTRAZENICA DRUG APPROVAL MOOTED

Article Abstract:

US Food & Drug Administration clearance is close for AstraZeneca's Nexium ulcer drug, set for launch at the start of 2001. The US-based watchdog will issue clearance following agreement over certain aspects, such as labelling.

Publisher: Financial Times Ltd.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Digestive & Genito-Urinary Preps, Pharmaceutical industry, AstraZeneca PLC, AZN, Nexium (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Brief Article, Marketing
Similar abstracts:
  • Abstracts: US: MARS MAKES CHOCOLATE HEALTH CLAIMS. UK: ANOTHER TATE & LYLE PROFIT WARNING? UK: TATE & LYLE TO AXE 'MR CUBE' SUGAR SYMBOL
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.